Contingency Management for Behavior Change: Applications to Promote Brief Smoking Cessation Among Opioid-Maintained Patients

Experimental and Clinical Psychopharmacology

Volumn 19, Issue 1, 2011, Pages 20-30

  Dunn, Kelly E ^a,b   Saulsgiver, Kathryn A ^a,b   Sigmon, Stacey C ^a,b  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF VERMONT   (United States)

Author keywords

Buprenorphine; Contingency management; Methadone; Smoking; Smoking cessation

Indexed keywords

AMFEBUTAMONE; AMPHETAMINE; BUPRENORPHINE; COCAINE; DEXTROPROPOXYPHENE; METHADONE; NICOTINE; NICOTINE PATCH; OPIATE; OXYCODONE;

ARTICLE; BEHAVIOR CHANGE; BEHAVIOR THERAPY; CLINICAL TRIAL; CONTINGENCY MANAGEMENT; CONTROLLED CLINICAL TRIAL; DRUG ABUSE; HUMAN; OPIATE ADDICTION; RANDOMIZED CONTROLLED TRIAL; SMOKING CESSATION; SMOKING CESSATION PROGRAM; TREATMENT OUTCOME;

ANALGESICS, OPIOID; BEHAVIOR THERAPY; BUPROPION; FEMALE; HUMANS; MALE; MOTIVATION; OPIATE SUBSTITUTION TREATMENT; OPIOID-RELATED DISORDERS; PSYCHOTHERAPY, BRIEF; RECURRENCE; SMOKING; SMOKING CESSATION; SUBSTANCE ABUSE DETECTION; SUBSTANCE-RELATED DISORDERS; TREATMENT OUTCOME;

EID: 79952093276     PISSN: 10641297     EISSN: 19362293     Source Type: Journal    
DOI: 10.1037/a0022039     Document Type: Article

References (86)

1. Bigelow G.E., Stitzer M.L., Griffiths R.R., Liebson I.A. Contingency management approached to drug self-administration and drug abuse: Efficacy and limitations. Addictive Behaviors 1981, 6:241-252.
2. Bobo J.K., Gilchrist L.D., Schilling R.F., Noach B., Schinke S.P. Cigarette smoking cessation attempts by recovering alcoholics. Addictive Behaviors 1987, 12:209-215.
3. Bobo J.K., Slade J., Hoffman A.L. Nicotine addiction counseling for chemically dependent patients. Psychiatric Services 1995, 46:945-947.
4. Burling T.A., Marshall G.D., Seidner A.L. Smoking cessation for substance abuse inpatients. Journal of Substance Abuse 1991, 3:269-276.
5. Burling T.A., Ziff D.C. Tobacco smoking: A comparison between alcohol and drug abuse inpatients. Addictive Behaviors 1988, 13:185-190.
6. Campbell B.K., Wander N., Stark M.J., Holbert T. Treating cigarette smoking in drug-abusing clients. Journal of Substance Abuse Treatment 1995, 12:89-94.
7. Chait L.D., Griffiths R.R. Effects of methadone on human cigarette smoking and subjective ratings. The Journal of Pharmacology and Experimental Therapeutics 1984, 229:636-640.
8. Clark J.G., Stein M.D., McGarry K.A., Gogineni A. Interest in smoking cessation among injection drug users. The American Journal on Addictions 2001, 10:159-166.
9. Clemmey P., Brooner R., Chutuape M.A., Kidorf M., Stitzer M. Smoking habits and attitudes in a methadone maintenance treatment population. Drug and Alcohol Dependence 1997, 44:123-132.
10. Cropsey K.L., Eldridge G.D., Weaver M.F., Villalobos G.C., Stitzer M.L. Expired carbon monoxide levels in self-reported smokers and nonsmokers in prison. Nicotine and Tobacco Research 2006, 8:653-659.
11. Danaei G., Ding E.L., Mozaffarian D., Taylor B., Rehm J., Murray C.J., Ezzati M. The preventable causes of death in the United States: Comparative risk assessment of dietary, lifestyle and metabolic risk factors. PLoS Medicine 2009, 6(4):e1000058.
12. Dunn K.E., Sigmon S.C., Reimann E., Badger G.J., Heil S., Higgins S.T. A contingency-management intervention to promote initial smoking cessation among opioid-maintained patients. Experimental and Clinical Psychopharmacology 2010, 18:37-50.
13. Dunn K.E., Sigmon S.C., Reimann E., Heil S.H., Higgins S.T. Effects of smoking cessation on illicit drug use among opioid-maintained patients: A pilot study. Journal of Drug Issues 2009, 39:313-328.
14. Dunn K.E., Sigmon S.C., Thomas C.S., Heil S.H., Higgins S.T. Voucher-based contingent reinforcement of smoking abstinence among methadone-maintained patients: A pilot study. Journal of Applied Behavior Analysis 2008, 41:527-538.
15. Engstrom A., Adamsson C., Allebeck P., Rydberg U. Mortality in patients with substance abuse: A follow-up in Stockholm County, 1973-84. International Journal of Addictions 1991, 26:91-106.
16. Fagerström K.O., Schneider N.G. Measuring nicotine dependence: A review of the Fagerström Tolerance Questionnaire. Journal of Behavioral Medicine 1989, 12:159-182.
17. Fiore M.C., Jaen C.R., Baker T.B., Bailey W.C., Benowitz N., Curry S.J., Wewers M.E. Treating tobacco use and dependence: 2008 update practice guideline 2008, U.S. Department of Health and Human Services, Public Health Services, Rockville, MD.
18. Friedmann P.D., Jiang L., Richter K.P. Cigarette smoking cessation services in outpatient substance abuse treatment programs in the United States. Journal of Substance Abuse Treatment 2008, 34:165-172.
19. Frosch D.L., Nahom D., Shoptaw S. Optimizing smoking cessation outcomes among the methadone maintained. Journal of Substance Abuse Treatment 2002, 23:425-430.
20. Frosch D.L., Shoptaw S., Jarvik M.E., Rawson R.A., Ling W. Interest in smoking cessation among methadone maintained outpatients. Journal of Addictive Disorders 1998, 17:9-19.
21. Fuller B.E., Guydish J., Tsoh J., Reid M.S., Resnick M., Zammarelli L., McCarty D. Attitudes toward the integration of smoking cessation treatment into drug abuse clinics. Journal of Substance Abuse Treatment 2007, 32:53-60.
22. Gonzales D., Rennard S.I., Nides M., Oncken C., Azoulay S., Billing C.B., Reeves K.R. Varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, vs. sustained-release bupropion and placebo for smoking cessation: A randomized controlled trial. Journal of the American Medical Association 2006, 296:47-55. Varenicline Phase 3 Study Group.
23. Gourlay S.G., Forbes A., Marriner T., Pethica D., McNeil J.J. Prospective study of factors predicting outcome of transdermal nicotine treatment in smoking cessation. British Medical Journal 1994, 309:842-846.
24. Gray, K. M., Carpenter, M. J., Baker, N. L., Hartwell, K. J., Lewis, A. L., Hiott, D. W., Upadhyaya, H. P. (2010). Bupropion SR and contingency management for adolescent smoking cessation. Journal of Substance Abuse Treatment. in press.
25. Guydish J., Passalacqua E., Tajima B., Manser S.T. Staff smoking and other barriers to nicotine dependence intervention in addiction treatment settings: A review. Journal of Psychoactive Drugs 2007, 39:423-433.
26. Haas A.L., Sorenson J.L., Hall S.M., Lin C., Delucchi K., Sporer K., Chen T. Cigarette smoking in opioid-using patients presenting for hospital-based medical services. American Journal on Addictions 2008, 17:65-69.
27. Hahn E.J., Warnick T.A., Plemmons S. Smoking cessation in drug treatment programs. Journal of Addictive Diseases 1999, 18:89-101.
28. Heatherton T.F., Kozlowski L.T., Frecker R.C., Rickert W., Robinson J. Measuring the heaviness of smoking: Using self-reported time to first cigarette of the day and number of cigarettes smoked per day. British Journal of Addiction 1989, 84:791-799.
29. Higgins S.T., Budney A.J., Hughes J.R., Bickel W.K., Lynn M., Mortensen A. Influence of cocaine use on cigarette smoking. Journal of the American Medical Association 1994, 272:1724.
30. Higgins S.T., Delaney D.D., Budney A.J., Bickel W.K., Hughes J.R., Foerg F., Fenwick J.W. A behavioral approach to achieving initial cocaine abstinence. American Journal of Psychiatry 1991, 148:1218-1224.
31. Higgins S.T., Heil S.H., Dantona R., Donhman R., Matthews M., Badger G.J. Effects of varying monetary value of voucher-based incentives on abstinence achieved during and following treatment among cocaine-dependent outpatients. Addiction 2007, 102:271-281.
32. Higgins S.T., Heil S.H., Dumeer A.M., Thomas C.S., Solomon L.J., Bernstein I.M. Smoking status in the initial weeks of quitting as a predictor of smoking-cessation outcomes in pregnant women. Drug and Alcohol Dependence 2006, 85:138-141.
33. Higgins S.T., Silverman K., Heil S.H. Contingency management in substance abuse treatment 2008, The Guilford Press, New York.
34. Hser Y.I., McCarthy W.J., Anglin M.D. Tobacco use as a distal predictor of mortality among long-term narcotic addicts. Preventative Medicine 1994, 23:61-69.
35. Hughes J.R., Gulliver S.B., Fenwick J.W., Valliere W.A., Cruser K., Pepper S., Flynn B.S. Smoking cessation among self-quitters. Health Psychology 1992, 11:331-334.
36. Hughes, J. R., Stead, L. F., & Lancaster, T. (2009). Antidepressants for smoking cessation. The Cochrane Database of Systematic Reviews, Issue 1. Art. No. CD000031. DOI: 10.1002/14651858.CD000031.pub3. Retrieved from http://www2.cochrane.org/reviews/en/ab000031.html.
37. Hurt R.D., Offord K.P., Croghan I.T., Gomez-Dahl L., Kottke T.E., Morse R.M., Melton L.J. Mortality following inpatient addictions treatment: Role of tobacco use in a community-based cohort. Journal of the American Medical Association 1996, 275:1097-1103.
38. Javors M.A., Hatch J.P., Lamb R.J. Cut-off levels for breath carbon monoxide as a marker for cigarette smoking. Addiction 2005, 100:159-167.
39. John U., Meyer C., Rumpf H.J., Hapke U. Smoking, nicotine dependence and psychiatric comorbidity- a population-based study including smoking cessation after three years. Drug and Alcohol Dependence 2004, 76:287-295.
40. Jorenby D.E., Hays J.T., Rigotti N.A., Azoulay S., Watsky E.J., Williams K.E., Reeves K.R. Efficacy of varenicline, a alpha4beta2 nicotinic acetylcholine receptor partial agonist, vs. placebo or sustained-release bupropion for smoking cessation: A randomized clinical trial. Journal of the American Medical Association 2006, 296:56-63. Varenicline Phase 3 Study Group.
41. Kenford S.L., Fiore M.C., Jorenby D.E., Smith S.S., Wetter D., Baker T.B. Predicting smoking cessation: Who will quit with and without the nicotine patch. Journal of the American Medical Association 1994, 271:589-594.
42. Knapp J.M., Rosheim C.L., Meister E.A., Kotttke T.E. Managing tobacco dependence in chemical dependency treatment facilities: A survey of current attitudes and policies. Journal of Addictive Diseases 1993, 12:89-104.
43. Knudsen H.K., Studts J.L. The implementation of tobacco-related brief interventions in substance abuse treatment: A national study of counselors. Journal of Substance Abuse Treatment 2010, 38:212-219.
44. Kohn C.S., Tsoh J.Y., Weisner C.M. Changes in smoking status among substance abusers: Baseline characteristics and abstinence from alcohol and drugs at 12-month follow-up. Drug and Alcohol Dependence 2003, 69:61-71.
45. Kozlowski L.T., Skinner W., Kent C., Pope M.A. Prospects for smoking treatment in individuals seeking treatment for alcohol and other drug problems. Addictive Behavior 1989, 14:273-278.
46. Krejci J., Steinberg M.L., Ziedonis D. Smoking status and substance abuse severity in a residential treatment sample. Drug and Alcohol Dependence 2003, 72:249-254.
47. Lemon S.C., Friedmann P.D., Stein M.D. The impact of smoking cessation on drug abuse treatment outcomes. Addictive Behaviors 2003, 28:1323-1331.
48. Lerman C., Kaufmann V., Rukstalis M., Patterson F., Perkins K., Audrain-McGovern J., Benowitz N. Individualizing nicotine replacement therapy for the treatment of tobacco dependence: A randomized trial. Annals of Internal Medicine 2004, 140:426-433.
49. Lussier J.P., Heil S.H., Mongeon J.A., Badger G.A., Higgins S.T. A meta-analysis of voucher-based reinforcement therapy for substance use disorders. Addiction 2006, 101:192-203.
50. Mello N.K., Lukas S.E., Mendelson J.H. Buprenorphine effects on cigarette smoking. Psychopharmacology 1985, 86:417-425.
51. Mello N.K., Mendelson J.H., Sellers M.L., Kuehnle J.C. Effects of heroin self-administration on cigarette smoking. Psychopharmacology 1980, 67:45-52.
52. Messer K., Trinidad D.R., Al-Delaimy W.K., Pierce J.P. Smoking cessation rates in the United States: A comparison of young adult and older smokers. American Journal of Public Health 2008, 98:317-322.
53. Mooney M.E., Poling J., Gonzalez G., Gonsai K., Kosten T., Sofuoglu M. Preliminary study of buprenorphine and bupropion for opioid-dependent smokers. The American Journal on Addictions 2008, 17:287-292.
54. Mutschler N.H., Stephen B.J., Teoh S.K., Mendelson J.H., Mello N.K. An inpatient study of the effects of buprenorphine on cigarette smoking in men concurrently dependence on cocaine and opioids. Nicotine and Tobacco Research 2002, 4:223-228.
55. Nahvi S., Richter K., Li X., Modali L., Arnsten J. Cigarette smoking and interest in quitting in methadone maintenance patients. Addictive Behaviors 2006, 31:2127-2134.
56. Olsen Y., Alford D.P., Horton N.J., Saitz R. Addressing smoking cessation in methadone programs. Journal of Addictive Diseases 2005, 24:33-48.
57. Petry N.M. A comprehensive guide for the application of contingency management procedures in standard clinic settings. Drug and Alcohol Dependence 2000, 58:9-25.
58. Prochaska J.J., Delucchi K., Hall S.M. A meta-analysis of smoking cessation interventions with individuals in substance abuse treatment or recovery. Journal of Consulting and Clinical Psychology 2004, 72:1144-1156.
59. Raiff B.R., Faix C., Turturici M., Dallery J. Breath carbon monoxide output is affected by speed of emptying the lungs: Implications for laboratory and smoking cessation research. Nicotine and Tobacco Research 2010, 12:834-838.
60. Reid M.S., Fallon B., Sonne S., Flammino F., Nunes E.V., Jiang H., Rotrosen J. Smoking cessation treatment in community-based substance-abuse rehabilitation programs. Journal of Substance Abuse Treatment 2008, 35:68-77.
61. Richter K.P. Good and bad times for treating cigarette smoking in drug treatment. Journal of Psychoactive Drugs 2006, 38:311-315.
62. Richter K.P., Choi W.S., Alford D.P. Smoking policies in U.S. outpatient drug treatment facilities. Nicotine and Tobacco Research 2005, 7:475-480.
63. Richter K.P., Choi W.S., McCool R.M., Harris K.J., Ahluwalia J.S. Smoking cessation services in U.S. methadone maintenance facilities. Psychiatric Services 2004, 55:1258-1264.
64. Richter K.P., Gibson C.A., Ahluwalia J.S., Schmelzle K.H. Tobacco use and quit attempts among methadone maintenance clients. America Journal of Public Health 2001, 91:296-299.
65. Richter K.P., Hamilton A.K., Hall S., Cately D., Cox L.S., Grobe J. Patterns of smoking and methadone dose in drug treatment patients. Experimental and Clinical Psychopharmacology 2007, 15:144-153.
66. Richter K.P., McCool R.M., Catley D., Hall M., Ahluwalia J.S. Dual pharmacotherapy and motivational interviewing for tobacco dependence among drug treatment patients. Journal of Addictive Diseases 2005, 24:79-90.
67. Richter K.P., McCool R.M., Okuyemi K.S., Mayo M.S., Ahluwalia J.S. Patients' views on smoking cessation and tobacco harm reduction during drug treatment. Nicotine and Tobacco Research 2002, 4(Suppl. 2):S175-S182.
68. Roll J.M., Higgins S.T., Tidey J.W. Cocaine use can increase cigarette smoking: Evidence from laboratory and naturalistic settings. Experimental and Clinical Psychopharmacology 1997, 5:263-268.
69. Schmitz J.M., Grabowski J., Rhoades H. The effects of high and low doses of methadone on cigarette smoking. Drug and Alcohol Dependence 1994, 34:237-242.
70. Schmitz J.M., Rhoades H., Grabowski J. Contingent reinforcement for reduced carbon monoxide levels in methadone maintenance patients. Addictive Behaviors 1995, 20:171-179.
71. Sees K.L., Clark H.W. When to begin smoking cessation in substance abusers. Journal of Substance Abuse Treatment 1993, 10:189-195.
72. Shiffman S., Johnston J.A., Khayrallah M., Elash C.A., Gwaltney C.J., Paty J.A., DeVeaugh-Geiss J. The effect of bupropion on nicotine craving and withdrawal. Psychopharmacology 2000, 148:33-40.
73. Shoptaw S., Jarvik M.E., Ling W., Rawson R.A. Contingency management for tobacco smoking in methadone-maintained opiate addicts. Addictive Behavior 1996, 21:409-412.
74. Shoptaw S., Rotheram-Fuller E., Yang X., Frosch D., Nahom D., Jarvik M.E., Ling W. Smoking cessation in methadone maintenance. Addiction 2002, 97:1317-1328.
75. Sigmon S.C., Lamb R.J., Dallery J. Tobacco. Contingency Management in Substance Abuse Treatment 2008, 99-119. The Guilford Press, New York. S.T. Higgins, K. Silverman, S.H. Heil (Eds.).
76. Silverman K., Chutuape M.A., Bigelow G.E., Stitzer M.L. Voucher-based reinforcement of cocaine abstinence in treatment-resistant methadone patients: Effects of reinforcement magnitude. Psychopharmacology 1999, 146:128-138.
77. Biochemical verification of tobacco use and cessation. Nicotine and Tobacco Research 2002, 4:149-159. SRNT Subcommittee on Biochemical Verification.
78. Stapleton J.A., Keaney F., Sutherland G. Illicit drug use as a predictor of smoking cessation treatment outcome. Nicotine and Tobacco Research 2009, 11:685-689.
79. Stein M.D., Anderson B.J., Niaura R. Nicotine replacement therapy: Patterns of use after a quit attempt among methadone-maintained smokers. Journal of General Internal Medicine 2006, 21:753-757.
80. Stein M.D., Weinstock M.C., Herman D.S., Anderson B.J., Antholy J.L., Niaura R. A smoking cessation intervention for the methadone-maintained. Addiction 2006, 101:599-607.
81. Stitzer M.L., Bigelow G.E. Contingent reinforcement for carbon monoxide reduction: Within-subjects effects of pay amounts. Journal of Applied Behavior Analysis 1984, 17:477-483.
82. Story J., Stark M.J. Treating cigarette smoking in methadone maintenance clients. Psychoactive Drugs 1991, 23:203-215.
83. Substance Abuse and Mental Health Services Administration. (2010). Results from the 2009 National Survey on Drug Use and Health: National Findings (Office of Applied Studies, NSDUH Series H-38A, HHS Publication No. SMA 10-4856 Findings). Rockville, MD.
84. Substance Abuse and Mental Health Services Administration, Office of Applied Studies. (2010). National Survey of Substance Abuse Treatment Services (N-SSATS): 2008: Data on Substance Abuse Treatment Facilities (DASIS Series: S-49, DHHS Publication No. (SMA) 09-4451). Rockville, MD.
85. West R., Baker C.L., Cappelleri J.C., Bushmakin A.G. Effect of varenicline and bupropion SR on craving, nicotine withdrawal symptoms, and rewarding effects of smoking during a quit attempt. Psychopharmacology 2008, 197:371-377.
86. Yudkin P.L., Jones L., Lancaster T., Fowler G.H. Which smokers are helped to give up smoking using transdermal nicotine patches? Results from a randomized, double-blind, placebo-controlled trial. British Journal of General Practice 1996, 46:145-148.